Molecular Partners AG - ADR Forecast, price target & analysts
Molecular Partners AG - ADR Target price 2025 - Analyst rating & recommendation
Molecular Partners AG - ADR Classifications & Recommendation:
Molecular Partners AG - ADR Price Target
| Target Price | $9.49 |
| Price | $4.08 |
| Potential |
132.59%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Molecular Partners AG - ADR 2026 .
The average Molecular Partners AG - ADR target price is $9.49.
This is
132.59%
register free of charge
$19.21
370.84%
register free of charge
$4.52
10.72%
register free of charge
|
|
| A rating was issued by 7 analysts: 5 Analysts recommend Molecular Partners AG - ADR to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Molecular Partners AG - ADR stock has an average upside potential 2026 of
132.59%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 5.64 | 0.57 |
| 27.97% | 89.98% | |
| EBITDA Margin | -1,184.75% | -12,325.03% |
| 42.04% | 940.30% | |
| Net Margin | -1,176.38% | -10,314.39% |
| 19.00% | 776.79% |
4 Analysts have issued a sales forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an Molecular Partners AG - ADR EBITDA forecast 2025. The average Molecular Partners AG - ADR EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Molecular Partners AG - ADR 2025 . The average Molecular Partners AG - ADR net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -1.80 | -1.58 |
| 14.29% | 12.22% | |
| P/E | negative | |
| EV/Sales | negative |
1 Analysts have issued a Molecular Partners AG - ADR forecast for earnings per share. The average Molecular Partners AG - ADR EPS is
This results in the following potential growth metrics and future valuations:
Molecular Partners AG - ADR...
Current Molecular Partners AG - ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| TD COWEN |
Locked
➜
Locked
|
Locked | Mar 13 2025 |
| TD COWEN |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
TD COWEN:
Locked
➜
Locked
|
Mar 13 2025 |
|
Locked
TD COWEN:
Locked
➜
Locked
|
Oct 31 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
